Showing results (101-110 of 162) with videos related to
Sort By:
Pageof 17
Frontiers in Bioengineering and Biotechnology|March 3, 2020
Engineering Targeting Materials for Therapeutic Cancer VaccinesPriscilla S Briquez, Sylvie Hauert, Alexandre de Titta, et al.Molecular Cancer Therapeutics|August 12, 2018
Improving Efficacy and Safety of Agonistic Anti-CD40 Antibody Through Extracellular Matrix AffinityJun Ishihara, Ako Ishihara, Lambert Potin, et al.Virology|October 1, 2017
Oxidation-sensitive polymersomes as vaccine nanocarriers enhance humoral responses against Lassa virus envelope glycoproteinClara Galan-Navarro, Marcela Rincon-Restrepo, Gert Zimmer, et al.Biomaterials|May 21, 2013
The promotion of endothelial cell attachment and spreading using FNIII10 fused to VEGF-A165Stephanie Traub, Jessica Morgner, Mikaël M Martino, et al.Biomaterials|April 14, 2017
Vaccine nanocarriers: Coupling intracellular pathways and cellular biodistribution to control CD4 vs CD8 T cell responsesMarcela Rincon-Restrepo, Aaron Mayer, Sylvie Hauert, et al.Journal of the National Cancer Institute|January 6, 2005
Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibodyBronislaw Pytowski, Jeremy Goldman, Kris Persaud, et al.Science Translational Medicine|November 10, 2017
Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse eventsJun Ishihara, Kazuto Fukunaga, Ako Ishihara, et al.European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|May 29, 2018
Experimental Drainage Device to Reduce Lymphoedema in a Rat ModelValentina Triacca, Marco Pisano, Claudia Lessert, et al.Cancer Research|March 15, 2012
Tumor microenvironment complexity: emerging roles in cancer therapyMelody A Swartz, Noriho Iida, Edward W Roberts, et al.Science Advances|December 18, 2019
Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapyJohn-Michael Williford, Jun Ishihara, Ako Ishihara, et al.Pageof 17